We will be at the?American Neurological Association?Annual Meeting in Orlando, Florida this week, presenting findings from our latest Phase 2 and Phase 3 research in #Parkinsonsdisease and #ALS. We look forward to connecting with our U.S. colleagues and the broader scientific community. #ANA2024 Learn more about our presentations:?bit.ly/3TrngbA
关于我们
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: https://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf
- 网站
-
https://www.mt-pharma-america.com/
Mitsubishi Tanabe Pharma America的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Jersey City，NJ
- 类型
- 私人持股
- 创立
- 2016
- 领域
- pharmaceutical products、amyotrophic lateral sclerosis、rare disease、innovation、research and development和global business
地点
-
主要
获取路线
US，NJ，Jersey City
Mitsubishi Tanabe Pharma America员工
-
Howard Levine
Associate Director,Healthcare Intelligence | Digital Biomarkers | Wearables | Decentralized Clinical Trials ?? | Beyond the Pill ?? | Health IoT ??
-
Glenn Bubb
-
Lia Thornton
Sr. Director, Multichannel Marketing & Patient Support at Mitsubishi Tanabe Pharma America
-
Gayatri Bhasin
Associate Director, Multichannel Marketing & Patient Support
动态
-
We’re looking forward to attending the 11th?Mobile in Clinical Trials?and #DPHARM2024 conferences!?Hao Zhang, PhD, MBA, Director, Digital Healthcare Innovation, Business & Product Strategy, MTPA and industry colleagues will discuss how wearable devices can help transform data collection. Hear more from Hao below! #MobileClin2024
-
We know that people with ALS and their families never give up, and neither do we. Our researchers are dedicated to expanding our understanding of ALS to help make a difference in the lives of people living with this disease.? Learn more: bit.ly/3uTwG6l?
-
Each year, nearly 90,000 Americans over the age of 65 are diagnosed with #ParkinsonsDisease. At MTPA, we're committed to supporting the entire PD community across generations, and today on #NationalGrandparentsDay, we honor the incredible grandparents who inspire our dedication to advancing PD research.
-
-
We recently supported the Central Coast Ride & Rally to Cure ALS presented by the?ALS Network. This community-driven event helped support the ALS Network’s mission priorities related to essential care services and cutting-edge research. Special shoutout to our very own?Claudette Eastwood, Neurology Account Specialist, Rare Disease, MTPA for attending this event to support this necessary cause.??
-
-
To help advance #ALS research, we’re collaborating with the Muscular Dystrophy Association on a study aimed at using investigational digital technology to provide additional indicators of ALS disease progression compared to existing standards.?? ? Learn more about the ALS Go-Digital study: https://bit.ly/3WOphPY??
-
Our very own, Joseph Scalia, Senior Vice President, Head of Commercial and Greg Mitchell, Regional Business Director, Neurology braved the chill at the #CEOSoak Syracuse to support the #ALS community.?? ? We’re honored to help raise awareness for The ALS Association’s mission to empower people living with ALS and fund vital research. Events like these are crucial for raising awareness and making a difference in the lives of those affected by ALS. #ALSAwareness
-
-
We’re excited to attend the 3rd Digital Biomarkers & Clinical Measures for Neurology Summit where Sharon Tamir, Senior Director of Digital Healthcare Innovation, Business & Research Strategy, MTPA will present insights on how digital objective measurement techniques can help track disease progression in #ALS and other neurological disorders.?? ? Learn more: https://bit.ly/3yCG68F??
-
-
Check out the video of Akihiro Tsujimura, Executive Vice President and Head of Pharma, Mitsubishi Chemical Group, participating in the 10th anniversary Ice Bucket Challenge. Together, we continue in our shared legacy of tackling debilitating diseases like ALS. #IceBucket10?
-
Our work is built on a 100-year legacy of helping to solve complex challenges in medical research. Explore how we’re advancing scientific discovery for debilitating diseases: bit.ly/3uTwG6l??